Early analysis of surrogate endpoints for metastatic melanoma in immune checkpoint inhibitor trials.
about
Pembrolizumab use for the treatment of advanced melanoma.Surrogate end points for overall survival in trials of PD-(L)1 inhibitors for urinary cancers: a systematic review.A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer.
P2860
Early analysis of surrogate endpoints for metastatic melanoma in immune checkpoint inhibitor trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Early analysis of surrogate en ...... e checkpoint inhibitor trials.
@en
type
label
Early analysis of surrogate en ...... e checkpoint inhibitor trials.
@en
prefLabel
Early analysis of surrogate en ...... e checkpoint inhibitor trials.
@en
P2093
P2860
P31
P1433
P1476
Early analysis of surrogate en ...... e checkpoint inhibitor trials.
@en
P2093
Andrea Coinu
Fausto Petrelli
Karen Borgonovo
Mara Ghilardi
Mary Cabiddu
Sandro Barni
Veronica Lonati
P2860
P356
10.1097/MD.0000000000003997
P407
P5008
P577
2016-06-01T00:00:00Z